CTRI/2022/11/047102进行中（未招募）未知
euroimaging Ancillary Study of the IV Iron RAPIDIRON Trial
Bill and Melinda Gates Foundation0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •a. For the maternal participant in the RAPIDIRON Trial â?? a pregnancy that has not gone beyond the period for obtaining a fetal MRI (by scanning the mother at 32-35 weeks fetal gestational age);
- •b. An indication of the pregnant womanâ??s intent to deliver in the study area and to reside there so as to be available not only to complete RAPIDIRON participation but also to allow her and her offspring to participate in ancillary study visits;
- •c. Informed consent of the pregnant RAPIDIRON participant for her participation and that of her offspring in the ancillary trial;
- •d. Concurrent participation in the RAPIDIRON-KIDS follow-up study.
排除标准
- •a. If a fetal brain anomaly is found when the maternal participant undergoes an MRI at 32-35 weeks fetal gestational age, the dyad would be excluded from the ancillary study;
- •b. If any of the following occur, this would result in dyad ineligibility for participation or continued participation in this ancillary study: maternal blood transfusion after enrollment, a pregnancy ending in stillbirth, neonatal death, diagnosis in the offspring of moderate to severe hypoxic-ischemic encephalopathy (or HIE), and/or blood transfusion to the offspring.
研究者
相似试验
已完成
不适用
Neuroimaging Ancillary StudyIron Deficiency Anemia of PregnancyNeurodevelopmental Disorder of FoetusIron Deficiency Anemia TreatmentFetal Neurodevelopmental DisorderChild DevelopmentIron Deficiency AnemiaNCT05545527Thomas Jefferson University184
尚未招募
不适用
The indications, logistical factors, benefits and adverse effects of the use of iron transfusion during surgery for surgical patients with iron deficiency anaemia.Iron deficiency anaemia in the perioperative periodBlood - AnaemiaAnaesthesiology - Other anaesthesiologyACTRN12613000785707Dr Bojana Stepanovic25
招募中
4 期
INFERR - Iron Infusion in Haemodialysis Study: Effect of Intravenous Iron Polymaltose on survival and hospitalisation rates for Indigenous Patients with High Ferritin Levels on HaemodialysisKidney diseaseanaemiahigh ferritinlow transferrin saturationHaemodialysisBlood - AnaemiaRenal and Urogenital - Kidney diseaseInflammatory and Immune System - Other inflammatory or immune system disordersOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonLiver diseaseACTRN12620000705987Menzies School of Health Research576
已完成
4 期
Rapid Administration of iron Polymaltose whilst In the operating Department for patients with iron deficiencyThe RAPID StudyIron deficiencyBlood - AnaemiaBlood - Other blood disordersACTRN12613000356763Dr Roger M Browning100
进行中（未招募）
不适用
A comparative study of low molecular weight IV iron dextran (CosmoFer®) versus per os iron for the treatment of anaemia in patients with haematological malignancies receiving epoietin treatmentFe deficiency anaemiaMedDRA version: 9.1Level: PTClassification code 10002034Term: AnaemiaEUCTR2007-005777-57-GRHospital Errikos Dunant- Department of Hematology110